A citation-based method for searching scientific literature

Esra Tara, Ariel Vitenzon, Ellen Hess, Kamran Khodakhah. Dis Model Mech 2018
Times Cited: 5







List of co-cited articles
9 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Decreases in the precision of Purkinje cell pacemaking cause cerebellar dysfunction and ataxia.
Joy T Walter, Karina Alviña, Mary D Womack, Carolyn Chevez, Kamran Khodakhah. Nat Neurosci 2006
269
60

Pearls & Oy-sters: Episodic ataxia type 2: Case report and review of the literature.
Elan L Guterman, Brian Yurgionas, Alexandra B Nelson. Neurology 2016
11
40

KCa channels as therapeutic targets in episodic ataxia type-2.
Karina Alviña, Kamran Khodakhah. J Neurosci 2010
72
40


Cerebellar ataxia by enhanced Ca(V)2.1 currents is alleviated by Ca2+-dependent K+-channel activators in Cacna1a(S218L) mutant mice.
Zhenyu Gao, Boyan Todorov, Curtis F Barrett, Stijn van Dorp, Michel D Ferrari, Arn M J M van den Maagdenberg, Chris I De Zeeuw, Freek E Hoebeek. J Neurosci 2012
60
40

Increased noise level of purkinje cell activities minimizes impact of their modulation during sensorimotor control.
F E Hoebeek, J S Stahl, A M van Alphen, M Schonewille, C Luo, M Rutteman, A M J M van den Maagdenberg, P C Molenaar, H H L M Goossens, M A Frens,[...]. Neuron 2005
107
40

The therapeutic mode of action of 4-aminopyridine in cerebellar ataxia.
Karina Alviña, Kamran Khodakhah. J Neurosci 2010
111
40

Spatiotemporal firing patterns in the cerebellum.
Chris I De Zeeuw, Freek E Hoebeek, Laurens W J Bosman, Martijn Schonewille, Laurens Witter, Sebastiaan K Koekkoek. Nat Rev Neurosci 2011
228
40

Cerebellar associative sensory learning defects in five mouse autism models.
Alexander D Kloth, Aleksandra Badura, Amy Li, Adriana Cherskov, Sara G Connolly, Andrea Giovannucci, M Ali Bangash, Giorgio Grasselli, Olga Peñagarikano, Claire Piochon,[...]. Elife 2015
63
40

Paroxysmal motor disorders: expanding phenotypes lead to coalescing genotypes.
Laura Zima, Sophia Ceulemans, Gail Reiner, Serena Galosi, Dillon Chen, Michelle Sahagian, Richard H Haas, Keith Hyland, Jennifer Friedman. Ann Clin Transl Neurol 2018
7
20


New insights into the pathogenesis and therapeutics of episodic ataxia type 1.
Maria Cristina D'Adamo, Sonia Hasan, Luca Guglielmi, Ilenio Servettini, Marta Cenciarini, Luigi Catacuzzeno, Fabio Franciolini. Front Cell Neurosci 2015
38
20

Consensus paper: management of degenerative cerebellar disorders.
W Ilg, A J Bastian, S Boesch, R G Burciu, P Celnik, J Claaßen, K Feil, R Kalla, I Miyai, W Nachbauer,[...]. Cerebellum 2014
87
20

In vivo impact of presynaptic calcium channel dysfunction on motor axons in episodic ataxia type 2.
Susan E Tomlinson, S Veronica Tan, David Burke, Robyn W Labrum, Andrea Haworth, Vaneesha S Gibbons, Mary G Sweeney, Robert C Griggs, Dimitri M Kullmann, Hugh Bostock,[...]. Brain 2016
8
20

Next-generation sequencing identifies novel CACNA1A gene mutations in episodic ataxia type 2.
Neven Maksemous, Bishakha Roy, Robert A Smith, Lyn R Griffiths. Mol Genet Genomic Med 2016
21
20

Episodic ataxia type 1: clinical characterization, quality of life and genotype-phenotype correlation.
Tracey D Graves, Yoon-Hee Cha, Angelika F Hahn, Richard Barohn, Mohammed K Salajegheh, Robert C Griggs, Brian N Bundy, Joanna C Jen, Robert W Baloh, Michael G Hanna. Brain 2014
52
20

Mutation Spectrum in the CACNA1A Gene in 49 Patients with Episodic Ataxia.
Cèlia Sintas, Oriel Carreño, Noèlia Fernàndez-Castillo, Roser Corominas, Marta Vila-Pueyo, Claudio Toma, Ester Cuenca-León, Isabel Barroeta, Carles Roig, Víctor Volpini,[...]. Sci Rep 2017
20
20

Aminopyridines for the treatment of neurologic disorders.
Michael Strupp, Julian Teufel, Andreas Zwergal, Roman Schniepp, Kamran Khodakhah, Katharina Feil. Neurol Clin Pract 2017
27
20

Update on the pharmacotherapy of cerebellar and central vestibular disorders.
Roger Kalla, Julian Teufel, Katharina Feil, Caroline Muth, Michael Strupp. J Neurol 2016
12
20

Primary episodic ataxias: diagnosis, pathogenesis and treatment.
J C Jen, T D Graves, E J Hess, M G Hanna, R C Griggs, R W Baloh. Brain 2007
197
20

Action potential broadening in a presynaptic channelopathy.
Rahima Begum, Yamina Bakiri, Kirill E Volynski, Dimitri M Kullmann. Nat Commun 2016
34
20

PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine.
Alice R Gardiner, Kailash P Bhatia, Maria Stamelou, Russell C Dale, Manju A Kurian, Susanne A Schneider, G M Wali, Tim Counihan, Anthony H Schapira, Sian D Spacey,[...]. Neurology 2012
108
20

Major intra-familial phenotypic heterogeneity and incomplete penetrance due to a CACNA1A pathogenic variant.
Chloé Angelini, Julien Van Gils, Antoine Bigourdan, Pierre-Simon Jouk, Didier Lacombe, Patrice Menegon, Sébastien Moutton, Florence Riant, Guilhem Sole, Elisabeth Tournier-Lasserve,[...]. Eur J Med Genet 2019
15
20


Case report of novel CACNA1A gene mutation causing episodic ataxia type 2.
David Alan Isaacs, Michael J Bradshaw, Kelly Brown, Peter Hedera. SAGE Open Med Case Rep 2017
6
20

Mutations underlying Episodic Ataxia type-1 antagonize Kv1.1 RNA editing.
Elizabeth A Ferrick-Kiddie, Joshua J C Rosenthal, Gregory D Ayers, Ronald B Emeson. Sci Rep 2017
12
20

The genetics of ataxia: through the labyrinth of the Minotaur, looking for Ariadne's thread.
M Mancuso, D Orsucci, G Siciliano, U Bonuccelli. J Neurol 2014
18
20

Clinical, genetic, neurophysiological and functional study of new mutations in episodic ataxia type 1.
Susan Elizabeth Tomlinson, Sanjeev Rajakulendran, Stella Veronica Tan, Tracey Dawn Graves, Doris-Eva Bamiou, Robyn W Labrum, David Burke, Carolyn M Sue, Paola Giunti, Stephanie Schorge,[...]. J Neurol Neurosurg Psychiatry 2013
31
20

Mechanism of accelerated current decay caused by an episodic ataxia type-1-associated mutant in a potassium channel pore.
Christian J Peters, Daniel Werry, Hira S Gill, Eric A Accili, David Fedida. J Neurosci 2011
7
20

Eye movement disorders are an early manifestation of CACNA1A mutations in children.
Esther M Tantsis, Deepak Gill, Lyn Griffiths, Sachin Gupta, John Lawson, Neven Maksemous, Robert Ouvrier, Florence Riant, Robert Smith, Christopher Troedson,[...]. Dev Med Child Neurol 2016
36
20

Acetazolamide-Responsive Episodic Ataxia Linked to Novel Splice Site Variant in FGF14 Gene.
M Schesny, F Joncourt, Alexander A Tarnutzer. Cerebellum 2019
9
20

Whole-exome sequencing as a diagnostic tool in a family with episodic ataxia type 1.
Pawel Tacik, Kimberly J Guthrie, Audrey J Strongosky, Daniel F Broderick, Douglas L Riegert-Johnson, Sha Tang, Dima El-Khechen, Alexander S Parker, Owen A Ross, Zbigniew K Wszolek. Mayo Clin Proc 2015
10
20

The clinical and genetic heterogeneity of paroxysmal dyskinesias.
Alice R Gardiner, Fatima Jaffer, Russell C Dale, Robyn Labrum, Roberto Erro, Esther Meyer, Georgia Xiromerisiou, Maria Stamelou, Matthew Walker, Dimitri Kullmann,[...]. Brain 2015
77
20

Pharmacotherapy of vestibular and ocular motor disorders, including nystagmus.
Michael Strupp, Matthew J Thurtell, Aasef G Shaikh, Thomas Brandt, David S Zee, R John Leigh. J Neurol 2011
61
20

Comprehensive systematic review summary: Treatment of cerebellar motor dysfunction and ataxia: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Theresa A Zesiewicz, George Wilmot, Sheng-Han Kuo, Susan Perlman, Patricia E Greenstein, Sarah H Ying, Tetsuo Ashizawa, S H Subramony, Jeremy D Schmahmann, K P Figueroa,[...]. Neurology 2018
39
20

Phenotypes, genotypes, and the management of paroxysmal movement disorders.
Laura Silveira-Moriyama, Stjepana Kovac, Manju A Kurian, Henry Houlden, Andrew J Lees, Matthew C Walker, Emmanuel Roze, Alex R Paciorkowski, Jonathan W Mink, Thomas T Warner. Dev Med Child Neurol 2018
19
20

A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias.
M Strupp, R Kalla, J Claassen, C Adrion, U Mansmann, T Klopstock, T Freilinger, H Neugebauer, R Spiegel, M Dichgans,[...]. Neurology 2011
108
20

EFNS guidelines on the molecular diagnosis of ataxias and spastic paraplegias.
T Gasser, J Finsterer, J Baets, C Van Broeckhoven, S Di Donato, B Fontaine, P De Jonghe, A Lossos, T Lynch, C Mariotti,[...]. Eur J Neurol 2010
33
20

Spinocerebellar ataxias: prospects and challenges for therapy development.
Tetsuo Ashizawa, Gülin Öz, Henry L Paulson. Nat Rev Neurol 2018
70
20

Selective positive modulator of calcium-activated potassium channels exerts beneficial effects in a mouse model of spinocerebellar ataxia type 2.
Adebimpe W Kasumu, Charlotte Hougaard, Frederik Rode, Thomas A Jacobsen, Jean Marc Sabatier, Birgitte L Eriksen, Dorte Strøbæk, Xia Liang, Polina Egorova, Dasha Vorontsova,[...]. Chem Biol 2012
78
20


Inferior olive and oculomotor system.
Neal H Barmack. Prog Brain Res 2006
23
20

Disruption of Purkinje cell function prior to huntingtin accumulation and cell loss in an animal model of Huntington disease.
S E Dougherty, J L Reeves, E K Lucas, K L Gamble, M Lesort, R M Cowell. Exp Neurol 2012
21
20

Abnormalities in the climbing fiber-Purkinje cell circuitry contribute to neuronal dysfunction in ATXN1[82Q] mice.
Justin A Barnes, Blake A Ebner, Lisa A Duvick, Wangcai Gao, Gang Chen, Harry T Orr, Timothy J Ebner. J Neurosci 2011
54
20






Ataxic Symptoms in Huntington's Disease Transgenic Mouse Model Are Alleviated by Chlorzoxazone.
Polina A Egorova, Aleksandra V Gavrilova, Ilya B Bezprozvanny. Front Neurosci 2020
4
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.